廣深鐵路股份(00525.HK)2022年度預虧18億元-22億元
格隆匯1月30日丨廣深鐵路股份(00525.HK)公佈,經公司財務部門初步測算,按中國企業會計準則,預計2022年度實現歸屬於上市公司股東的淨虧損約為人民幣18億元到22億元,歸屬於上市公司股東的扣除非經常性損益後的淨虧損約為人民幣19億元到23億元。
2022年,公司客貨運輸主營業務因受新冠肺炎疫情持續影響,旅客發送量和貨物發送量均出現較大幅度下降,從而導致公司2022年年度經營業績出現虧損。面對疫情,公司統籌疫情防控與安全生產經營,在切實做好常態化疫情防控工作的基礎上,積極通過調整客貨運輸組織、嚴格成本管控、強化風險防控等措施,最大限度降低疫情帶來的不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.